HIGHLIGHTS
- who: Koji Iinuma and colleagues from the Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Gifu, Japan have published the Article: Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study, in the Journal: Cancers 2022, 4579 of /2022/
- what: Although a relatively small number of participants were enrolled in this multicenter retrospective study, the oncological outcomes and TRAE profiles were equivalent to those of other studies.
- how: Data were analyzed using software JMP 14 (SAS Institute . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.